
Shanghai Rightongene Biotechnology Co., Ltd. announced that its wholly-owned subsidiary, Shanghai Yuanqi Biomedical Technology Co., Ltd., recently received a total of RMB 1.7629 million in government grants, which are government subsidies related to income.


About Yuanqi Biology
Shanghai Yuanqi Biomedical Technology Co., Ltd. was established in 2010 and headquartered in Fengxian District, Shanghai. It is a high-tech enterprise specializing in the field of biomedicine. The company focuses on the research, development, production, and sales of personalized molecular diagnostic reagents, while also providing technical consulting and services. As of 2024, the company's registered capital and paid-in capital are both 100 million RMB, and it is wholly owned by Shanghai Rightongene Biotechnology Co., Ltd. The company has been recognized as a high-tech enterprise, gazelle enterprise, technology little giant enterprise, and specialized, refined, unique, and innovative small and medium-sized enterprise. In 2024, it received a government subsidy of 1.05 million RMB.
-END-
Source: Corporate Announcement
Submission email:tougao@caivd-org.cn